Evidence map›Paper›PMID 28126936›Full record

ArticleGenome announcements2017

Draft Genome Sequence of an Erythromycin-Resistant Propionibacterium acnes Isolate Recovered from Folliculitis of the Scalp.

Guillaume Ghislain Aubin, Stanimir Kambarev, Aurélie Guillouzouic, Amir Khammari, Brigitte Dréno, Stéphane Corvec

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genome announcements, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Guillaume Ghislain AubinBacteriology and Hygiene department, Nantes University Hospital, Nantes, France.
Stanimir KambarevInstitut de Recherche en Santé de l'Université de Nantes INSERM U892-CNRS 6299 CRCNA Centre de Recherche en Cancérologie Nantes Angers Université de Nantes, Team 13: Nuclear Oncology Research, Nantes, France.
Aurélie GuillouzouicBacteriology and Hygiene department, Nantes University Hospital, Nantes, France.
Amir KhammariInstitut de Recherche en Santé de l'Université de Nantes INSERM U892-CNRS 6299 CRCNA Centre de Recherche en Cancérologie Nantes Angers Université de Nantes, Team 2: Clinical and Translational Research in Skin Cancer, Nantes, France.
Brigitte DrénoInstitut de Recherche en Santé de l'Université de Nantes INSERM U892-CNRS 6299 CRCNA Centre de Recherche en Cancérologie Nantes Angers Université de Nantes, Team 2: Clinical and Translational Research in Skin Cancer, Nantes, France.
Stéphane CorvecBacteriology and Hygiene department, Nantes University Hospital, Nantes, France stephane.corvec@chu-nantes.fr.ORCID http://orcid.org/0000-0003-3176-8111
Centre National de la Recherche Scientifique · FRNantes Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Propionibacterium acnes is now well-known and recognized for its implication in the pathogenesis of acne vulgaris. Here, we report the draft genome sequence of an erythromycin-resistant P. acnes strain isolated from a case of folliculitis of the scalp belonging to phylotype IA1 and sequence type 18 (ST18).

Identifiers

PMID28126936
PMCPMC5270695
OpenAlexW2580275323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.